Avicanna
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
480 University Ave Suite 1502, Toronto, ...Phone Number
(647) 243-5283Website
www.avicanna.comRevenue
$11.8 MillionStock Symbol
AVCN.TOIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Avicanna
Avicanna is an innovative biopharmaceutical company specializing in the development and commercialization of cannabinoid-based products for the medical and pharmaceutical markets. With a robust scientific platform, the company has successfully launched over thirty proprietary, evidence-based products and operates four commercial business pillars. Avicanna is dedicated to advancing the understanding and application of medical cannabis through extensive research and collaborations with leading academic and clinical institutions. The company aims to address global opportunities in the medical cannabis sector, leveraging its established infrastructure and intellectual property portfolio.Explore more
Avicanna Org Chart
NH
Chief Financial Officer
SK
Avicanna Inc Chief Legal Officer & General Co...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Avicanna your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Avicanna has new funding data
Avicanna, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Avicanna recently announced quarterly report
Click to see if Avicanna had a recent Job posting/layoffs
Product Launch: Get notified when Avicanna launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Avicanna
Check if Avicanna has recently received funding, and reach out quickly before it becomes old news!
Check out if Avicanna is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Avicanna
Find more new buyers
Compare Similar Companies to Avicanna
Compare insights from companies similar to Avicanna, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Avicanna is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Avicanna is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Avicanna.
Avicanna financials insights
Gather financial insights about Avicanna, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Angel/Seed
$1.2M
2018
Share Placement
$4.8M
2020
Share Placement
$2M
Debt
$1.1M
2021
Share Placement
$4.4M
Debt
$2.1M
Avicanna Tech Stack
A closer look at the technologies used by Avicanna
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Earnings, Business Finance, Finance
Person-Based
Earnings, Finance
Person-Based
Intellectual Property, Legal Affairs
Person-Based
Product Development, Product Launch, Pharmaceuticals
Avicanna News & Media
Avicanna to Present at a Life Sciences Investor Forum on September 17, 2026
TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”), a commercial-stage international biopharmaceutical company focused on cannabinoid-based medicines, is pleased to announce that Aras Azadian, CEO of Avicanna Inc. and Avicanna Inc. will be presenting live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026.Avicanna Launches MyMedi.ca Integrated Healthcare Program in Canada
Integrating MyMedi.ca healthcare provider-guided medical cannabis care into hospitals, specialty clinics, insurers and multidisciplinary healthcare networks in Canada Integrating MyMedi.ca healthcare provider-guided medical cannabis care into hospitals, specialty clinics, insurers and multidisciplinary healthcare networks in CanadaAvicanna Announces Closing of Strategic Non-Brokered Private Placement
Strategic investment by pharmaceutical executive and life sciences investor Michael Porter Strategic investment by pharmaceutical executive and life sciences investor Michael PorterAvicanna Reports Q2 2026 Financial Results
Gross margin improves to 57%, supported by 48% quarterly growth in proprietary product sales QUIX™ rapid-onset portfolio prepared for Q3 launch with more than 35 commercial listings secured
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Avicanna
Sign Up For FreeTo access detailed company insights
Avicanna is an innovative biopharmaceutical company specializing in the development and commercialization of cannabinoid-based products for the medical and pharmaceutical markets. With a robust scientific platform, the company has successfully launched over thirty proprietary, evidence-based products and operates four commercial business pillars. A... Read More
